References
- Biollaz J., Brunner H R, Gavras I., Waeber B, Gavras H. Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982; 4: 966–72
- Nicholls G M, Ikram H, Espiner E, Maslowski A H, Scandrett M S, Penman T. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. Am J Cardiol 1982; 49: 1497–501
- Barrett J D, Eggena P, Sambhi M P. Extraction and measurement of circulating angiotensins I and II. Clin Chem 1977; 23: 464–8
- Atkinson A B, Morton J J, Brown J J, et al. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J 1980; 44: 290–6
- Workman R J, Sussman C R, Burkitt D W, Liddle G W. Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med 1979; 93: 847–56
- Düsterdieck G, McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest 1971; 2: 32–8
- Boer P, Roos J C, Geyskes G G, Dorhout Mees E J. Observations on plasma renin substrate in the nephrotic syndrome. Nephron 1980; 26: 121–5
- Hene R J., Boer P, Koomans H A, Dorhout Mees E J. Plasma aldosterone concentrations in chronic renal disease. Kidney Int 1982; 21: 98–101
- Hurst P L, Lovell-Smith C J. Optimized assay for serum angiotensin-converting enzvme activity. Clin Chem 1981; 27: 2048–52
- Brunner D B, Desponds G, Biollaz J, et al. Effect of a new angiotensin enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Br J Clin Pharmacol 1981; 11: 461–7
- Gavras H, Waeber B, Gavras I, Biollaz J, Brunner H R, Davies R O. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor MK 421. Lancet 1981; ii: 543–6
- Rasmussen S, Nielsen M, Giese D. J. Captopril with thiazide lowers renin substrate concentration: implications for methodology in renin assays. Clin Sci 1981; 60: 591–3
- Semple P F, Boyd A S, Dawes P M, Morton J J. Angiotensin II and its hepta-, hexa-, and pentapeptide metabolites in arterial and venous blood of man. Circ Res 1976; 39: 671–8
- Giese J, Rasmussen S, Dankjaer Nielsen M, Ibsen H. Biochemical monitoring of vasoactive peptides during angiotensin converting enzyme inhibition. J Hypert 1983; 1(Suppl 1)31–6